Latest News and Press Releases
Want to stay updated on the latest news?
-
新泽西州，皮斯卡塔韦, July 25, 2019 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc.（Aucta）是一家专注从事品牌专业产品开发 与商业化的科技企业。近日，该公司宣布已与 上海复星医药（集团）股份有限公司（以下称“复星医药”）控股子公司江苏万邦生化医...
-
新澤西州，皮斯卡塔韋, July 25, 2019 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc.（Aucta）是一家專注從事品牌專業產品開發 與商業化的科技企業。近日，該公司今天宣布已與上海復星醫藥（集團）股份有限公司（以下稱“復星醫藥”）下屬的控股子公司江蘇萬 邦生化醫藥股份有限公司簽署排他性許可協議（以下稱“協議”） ...
-
PISCATAWAY, N.J., July 25, 2019 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc. (Aucta), a technology based company focusing on the development and commercialization of Branded Specialty Products,...
-
新泽西州PISCATAWAY, June 27, 2019 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc. (Aucta)是一家拥有特有技术平台的产品公司，公司致力于专科领域品牌产品的研发和商业化。该公司今天宣布已与Eton Pharmaceuticals, Inc.签订协议，将AUC025在美国市场的销售权给予Eton...
-
新澤西州，PISCATAWAY, June 27, 2019 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc. (Aucta)是一家擁有特有技術平臺的產品公司，公司致力於專科領域品牌產品的研發和商業化。該公司今天宣佈已與Eton Pharmaceuticals, Inc.簽訂協定，將AUC025在美國市場的銷售權給予Eton...
-
PISCATAWAY, N.J., June 27, 2019 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc. (Aucta), a technology based company focusing on the development and commercialization of Branded Specialty Products,...
-
美國新澤西州北布倫瑞克, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc. (Aucta) 今天宣佈其已與Oakrum Pharma, LLC (Oakrum) 達成一項協議，將開發並生產四種擬在美國以Oakrum商標進行商業化的處方仿製藥產品。 預計這些產品將供應予零售市場，包括口服液和局部用藥。...
-
北布伦瑞克,新泽西州, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc.（Aucta）今天宣布其已与Oakrum Pharma,...
-
NORTH BRUNSWICK, N.J., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc. (Aucta) announced today that it has entered into an agreement with Oakrum Pharma, LLC (Oakrum) to develop and...
-
NEW BRUNSWICK, N.J., July 16, 2018 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc. (Aucta) announced today that it has begun shipping Vigabatrin for Oral Solution, USP, 500 mg, following final...